Eli Lilly Drug Maintains Lean Mass During Weight Loss with Wegovy

TL;DR Summary
A Phase 2 trial shows that combining Eli Lilly's bimagrumab with Wegovy results in greater weight loss, primarily from fat, and better preservation of lean mass compared to Wegovy alone, with significant reductions in harmful visceral fat.
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
1 min
vs 1 min read
Condensed
80%
187 → 37 words
Want the full story? Read the original article
Read on STAT